Joel Mathews
Director - Biomarker Strategy, Organization Building, Neuroscience & Immunology Ionis Pharmaceuticals, Inc.
Joel Mathews, PhD, is Director, Biomarkers at Ionis Pharmaceuticals, a role held since January 2020, where he built the biomarker organization from the ground up. He joined Ionis in 2018 as Biomarker Discovery and Assay Development Group lead. Previously, he was a Scientist and immunology lead for biomarker development at Genentech.
Seminars
Friday 19th March 2027
Leveraging Blood-Based Biomarkers Beyond Oncology to Accelerate Clinical Trial Readouts
4:40 pm
- Applying assay development and validation practice built in oncology to blood-based biomarkers in neurodegeneration and other non-oncology indications
- Reducing reliance on invasive and costly procedures such as imaging and tissue or CSF sampling, lowering screening cost and widening trial recruitment
- Adapting sampling and operational models to diseases that progress over years rather than weeks
